MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease.
MicroRNAs are endogenous non-coding RNAs, approximately 22 nucleotides in length. They regulate gene expression and are important in a wide range of physiological and pathological processes. MicroRNA expression is tightly regulated during hematopoiesis and lymphoid cell differentiation and disruption of the entire microRNA network or selected microRNAs may lead to dysregulated immune responses. Abnormalities in microRNA expression related to inflammatory cytokines, Th-17 and regulatory T cells as well as B cells have been described in several autoimmune diseases. Sjogren's syndrome is characterized by features of systemic autoimmunity and chronic inflammation and dysfunction in exocrine organs. Its clinical characteristics along with the relatively easy access to the target tissue and its product makes Sjögren's syndrome appealing to study many aspects of microRNAs in a systemic autoimmune disease, such as their potential as diagnostic or prognostic biomarkers and their role in pathogenesis of autoimmunity, inflammation or organ dysfunction. Encouraging preliminary data from pilot studies in Sjogren's syndrome demonstrate the potential of microRNAs as putative diagnostic and prognostic biomarker candidates which should be tested in larger more definite studies. Combining the comparison of microRNA expression profiles between various clinical subsets of Sjögren's syndrome with bioinformatic modeling tools may predict formerly unsuspected pathways which may contribute to the disease process and lead to the generation of testable novel hypothesis of pathogenesis.
Alevizos
Ilias
I
Sjögren's Syndrome Clinic, Molecular Physiology & Therapeutics Branch, National Institute of Dental and Craniofacial Research, Bethesda, MD, USA.
Illei
Gabor G
GG
D001172:Arthritis, Rheumatoid / Q000235:genetics; D001327:Autoimmune Diseases / Q000235:genetics* / Q000276:immunology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000235:genetics; D035683:MicroRNAs / Q000235:genetics / Q000502:physiology*; D009103:Multiple Sclerosis / Q000235:genetics; D012859:Sjogren's Syndrome / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology
D035683:MicroRNAs
Mol Cell. 2007 May 25;26(4):523-37
17531811
Nature. 2008 Oct 23;455(7216):1124-8
18806776
Trends Cell Biol. 2008 May;18(5):199-209
18396047
Nat Immunol. 2009 Dec;10(12):1252-9
19838199
Arthritis Rheum. 2009 May;60(5):1294-304
19404929
Arthritis Res Ther. 2008;10(4):R101
18759964
Nat Cell Biol. 2007 Jun;9(6):654-9
17486113
Lancet. 2005 Jul 23-29;366(9482):321-31
16039337
PLoS One. 2007 Jul 11;2(7):e610
17622355
Nat Immunol. 2008 Aug;9(8):839-45
18645592
Cell Immunol. 2010;260(2):70-4
19954774
Nature. 2004 Nov 11;432(7014):235-40
15531877
Cell. 2006 Sep 22;126(6):1203-17
16990141
J Autoimmun. 2009 May-Jun;32(3-4):189-94
19303254
Curr Opin Rheumatol. 2009 Sep;21(5):465-70
19568172
Rheumatol Int. 2009 May;29(7):749-54
18998140
Nat Rev Immunol. 2008 Feb;8(2):120-30
18204468
Eur J Immunol. 2010 Mar;40(3):888-98
20148420
Nat Immunol. 2008 Apr;9(4):405-14
18327259
Arthritis Rheum. 2009 Apr;60(4):1065-75
19333922
Lupus. 2007;16(12):939-46
18042587
J Immunol. 2009 Apr 15;182(8):5088-97
19342689
Oral Dis. 2010 Jan;16(1):34-8
19627513
Curr Opin Mol Ther. 2009 Apr;11(2):189-99
19330724
Arthritis Rheum. 2008 May;58(5):1284-92
18438844
EMBO J. 2004 Oct 13;23(20):4051-60
15372072
Nat Clin Pract Rheumatol. 2008 Oct;4(10):534-41
18728632
J Autoimmun. 2009 May-Jun;32(3-4):246-53
19345069
J Clin Immunol. 2010 May;30(3):339-46
20191314
J Cell Sci. 2000 Oct;113 Pt 19:3365-74
10984428
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8866-71
18579786
Cell. 2008 Apr 18;133(2):217-22
18423194